Analysis of vaccines against equine rhinopneumonia of native and foreign production

UDC: 619: 616.988
DOI: 10.36871/vet.zoo.bio.202403010

Authors

Regina F. Ivannikova,
Ekaterina A. Smirnova,
Nikolay V. Pimenov,
Moscow State Academy of Veterinary Medicine and Biotechnology – MVA by K. I. Skryabin”, Moscow, Russia

Abstract

Equine rhinopneumonia is caused by two closely related viruses of the Herpesviridae family: equine herpesvirus-1 and equine herpesvirus-4 (EHV-1 and EHV-4). The disease is manifested by decreased performance of animals, in neglected cases by severe respiratory disease, abortion and paralysis. Outbreaks of rhinopneumonia have a negative impact on the livestock industry. A number of vaccines have been developed worldwide to prevent and control the infection. Despite the seriousness of the disease there are currently only a few well-studied strains of the virus that are the mainstay of vaccine development. Due to the dramatic increase in the number of rhinopneumonia outbreaks around the world, scientists have recently been faced with the need to isolate new strains of the virus. However, the creation of polyvalent associated vaccines has not yet yielded the desired results. The review article presents a comparison of domestic preparations with foreign ones. Analysis of the considered sources, based on the scientific achievements of foreign researchers, allows us to form a modern idea of the degree of preparation for the fight against infectious viral disease.

Keywords

EHV-1, EHV-4, specific prevention of equine herpesvirus-I and herpesvirus-II disease, live and inactivated vaccine.